Newly Diagnosed Email Series
Being diagnosed with ALS can bring a lot of unknowns, and trying to figure them out can feel overwhelming. Remember: we are here to help.
We have carefully curated this information to help people newly diagnosed with ALS and their loved ones so you do not feel overwhelmed with too much information at once. To sign up for the email series and receive these four emails over eight weeks, click here.
We have also compiled the contents of each email into a downloadable format below.
We will find cures for ALS. The only question is when. That answer depends on you.
Stay informed on I AM ALS’ progress and what you can do to help us make hope real.
Guide to Submitting Written Testimony to the FDA about AMX0035
On September 7, 2022, the FDA will host their second public advisory committee meeting (AdCom) about AMX0035.
ALS Organizations Unite in Support of AMX0035 Approval
ALS Organizations Unite in Support of AMX0035 Approval. Read their open letter.
Response to NINDS ALS Strategic Plan Request for Information
On Feb 10, 2022 I AM ALS submitted a response to the National Insititute of Neurological Disorders and Stroke (NINDS) ALS Strategic Plan Request for Information. NINDS is a part of the National Institute of Health (NIH), which is the largest public funder of ALS research.